Abrdn World Healthcare Fund (NYSE:THW) Trading Down 2.1% – Should You Sell?

Abrdn World Healthcare Fund (NYSE:THW)’s share price was down 2.1% during mid-day trading on Tuesday . The company traded as low as $12.45 and last traded at $12.5550. Approximately 141,685 shares traded hands during mid-day trading, an increase of 8% from the average daily volume of 131,589 shares. The stock had previously closed at $12.82.

Abrdn World Healthcare Fund Stock Performance

The firm’s 50-day moving average price is $12.42 and its 200 day moving average price is $12.56.

Abrdn World Healthcare Fund Dividend Announcement

The company also recently announced a monthly dividend, which was paid on Friday, May 29th. Shareholders of record on Thursday, May 21st were issued a dividend of $0.1167 per share. This represents a c) dividend on an annualized basis and a yield of 11.2%. The ex-dividend date of this dividend was Thursday, May 21st.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Advisory Services Network LLC acquired a new stake in shares of Abrdn World Healthcare Fund during the 3rd quarter valued at approximately $43,000. Ameriflex Group Inc. acquired a new position in Abrdn World Healthcare Fund in the third quarter worth $79,000. B. Riley Wealth Advisors Inc. bought a new stake in Abrdn World Healthcare Fund during the second quarter valued at $113,000. Mercer Global Advisors Inc. ADV bought a new stake in Abrdn World Healthcare Fund during the fourth quarter valued at $157,000. Finally, HighTower Advisors LLC acquired a new stake in shares of Abrdn World Healthcare Fund during the fourth quarter worth $168,000.

About Abrdn World Healthcare Fund

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.